Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • NF-κB
    (2)
  • Anti-infection
    (1)
  • Antibacterial
    (1)
  • Apoptosis
    (1)
  • Autophagy
    (1)
  • COX
    (1)
  • Carbonic Anhydrase
    (1)
  • Glucosidase
    (1)
  • Histone Demethylase
    (1)
  • Others
    (9)
TargetMol | Tags By ResearchField
  • Cancer
    (6)
  • Infection
    (2)
  • Inflammation
    (2)
  • Metabolism
    (2)
  • Immune System
    (1)
  • Others
    (1)
Filter
Search Result
Results for "

T6176

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    11
    TargetMol | All_Pathways
IKK 16
IKK-16, IKK16, IKK Inhibitor VII
T6176873225-46-8
IKK 16 (IKK Inhibitor VII) is a selective IκB kinase (IKK) inhibitor for IKK-2, IKK complex and IKK-1 with IC50 of 40 nM, 70 nM and 200 nM, respectively.
  • $34
In Stock
Size
QTY
TargetMol | Citations Cited
COX-2-IN-18
CDK9-IN-41
T617601038061-96-9
COX-2-IN-18 is a potent and selective COX-2 inhibitor (IC50 = 30 nM). It alleviates inflammation and pain by inhibiting PGE2 production in autoimmune research.
  • $58
In Stock
Size
QTY
α-Glucosidase-IN-21
T61761321686-01-5
α-Glucosidase-IN-21 (Compound 2B) is a highly potent, orally bioavailable α-glucosidase inhibitor with an IC50 value of 2.62 μM, demonstrating remarkable anti-diabetic properties [1].
  • $1,520
6-8 weeks
Size
QTY
Zika virus-IN-3
T617622527915-11-1
Zika virus-IN-3 (Compd 7) is a Zika virus inhibitor with an EC50 of 3.4 μM [1].
  • $1,520
8-10 weeks
Size
QTY
GRP-60367 hydrochloride
T61763
GRP-60367 hydrochloride is a novel small-molecule entry inhibitor of rabies virus (RABV), exhibiting nanomolar potency against select RABV strains. This first-in-class compound effectively targets the RABV G protein [1].
  • $1,690
1-2 weeks
Size
QTY
Zoledronic acid disodium tetrahydrate
T61764165800-07-7
Zoledronic Acid (Zoledronate) disodium tetrahydrate is a potent third-generation bisphosphonate (BP) with strong anti-resorptive activity, effectively inhibiting osteoclast differentiation and apoptosis, and demonstrating anti-cancer properties [1].
  • $1,520
1-2 weeks
Size
QTY
Microtubule inhibitor 5
T617652416338-55-9
Microtubule inhibitor 5 (compound 17f) is a highly potent cytotoxic agent that inhibits microtubule function, exhibiting a substantial cytotoxic effect on NCI-H460 cells with an IC50 value of 154.5 nM. Additionally, this compound demonstrates excellent cell permeability [1].
  • $1,520
6-8 weeks
Size
QTY
RSK4-IN-1
T617662755819-10-2
RSK4-IN-1 is a compound exhibiting potent inhibition of RSK4, demonstrated by an IC50 value of 9.5 nM.
  • $1,520
10-14 weeks
Size
QTY
IRAK4-IN-17
T617672183503-33-3
IRAK4-IN-17 (Compound 5) is a highly potent IRAK4 inhibitor with an IC50 value of 1.3 nM [1], and it is particularly valuable for research on large B-cell lymphoma (DLBCL) [1].
  • $1,520
6-8 weeks
Size
QTY
FY-56
T61768
FY-56, a highly potent and selective inhibitor of LSD1/KDM1A with an IC50 value of 42 nM, demonstrates significant selectivity over MAO-A/B. This compound effectively induces differentiation in MOLM-13 and MV4-11 cells, showing promise for acute myeloid leukemia (AML) research [1].
  • $1,520
10-14 weeks
Size
QTY
hCAXII-IN-5
T617692414629-92-6
hCAXII-IN-5 (compound 6o) is a highly effective and specific inhibitor of hCAXII, demonstrating impressive binding affinities with Ki values of >10000, >10000, 286.1, and 1.0 nM for hCAI, hCAII, hCAIX, and hCAXII, respectively [1].
  • $1,520
6-8 weeks
Size
QTY